» Cost-effectiveness and cost-utility of treating hepatitis C in patients with or without HIV infection: analysis according to HCV genotype, stage of hepatic fibrosis, hepatic fibrosis assessment of pre-treatment, use of non-invasive markers of liver fibrosis stage and HIV infection
Coordinator: Fernando Wolff
Researchers: Nêmora T. Barcellos, Ajacio B. Melo Brandão, Maria Letícia Ikeda, Paulo R Alencastro, Sandra C. Fuchs, Flávio D Fuchs